0001104659-20-100107.txt : 20200828
0001104659-20-100107.hdr.sgml : 20200828
20200828151915
ACCESSION NUMBER: 0001104659-20-100107
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200827
FILED AS OF DATE: 20200828
DATE AS OF CHANGE: 20200828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Jeffrey Allen
CENTRAL INDEX KEY: 0001500210
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 811-06565
FILM NUMBER: 201147538
MAIL ADDRESS:
STREET 1: KING PHARMACEUTICALS, INC.
STREET 2: 501 FIFTH STREET
CITY: BRISTOL
STATE: TN
ZIP: 37620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEKLA LIFE SCIENCES INVESTORS
CENTRAL INDEX KEY: 0000884121
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000]
IRS NUMBER: 043147016
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 100 FEDERAL STREET
STREET 2: 19TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 6177728515
MAIL ADDRESS:
STREET 1: 100 FEDERAL STREET
STREET 2: 19TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
FORMER COMPANY:
FORMER CONFORMED NAME: H&Q LIFE SCIENCES INVESTORS
DATE OF NAME CHANGE: 19920929
3
1
a3.xml
3
X0206
3
2020-08-27
1
0000884121
TEKLA LIFE SCIENCES INVESTORS
HQL
0001500210
Bailey Jeffrey Allen
C/O TEKLA LIFE SCIENCES INVESTORS
100 FEDERAL STREET, 19TH FLOOR
BOSTON
MA
02110
1
0
0
0
/s/ Jeffrey A. Bailey
2020-08-28